Medipost Co Ltd

XKRX:078160 (Korea (the Republic of))   Ordinary Shares
â‚© 9300.00 (-4.81%) Nov 28
At Loss
P/B:
1.10
Market Cap:
â‚© 317.12B ($ 227.00M)
Enterprise V:
â‚© 213.00B ($ 152.78M)
Volume:
432.23K
Avg Vol (2M):
258.67K
Trade In:
Volume:
432.23K
At Loss
Avg Vol (2M):
258.67K

Business Description

Description
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.
Name Current Vs Industry Vs History
Equity-to-Asset 0.68
Debt-to-Equity 0.04
Debt-to-EBITDA 0.5
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.77
Distress
Grey
Safe
Beneish M-Score -2.95
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 68.93
9-Day RSI 67.77
14-Day RSI 66.69
6-1 Month Momentum % -4.14
12-1 Month Momentum % -22.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.6
Quick Ratio 2.6
Days Inventory 184.72
Days Sales Outstanding 63.39
Days Payable 25.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.7
Shareholder Yield % 9.62
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Medipost Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 69,863.92
EPS (TTM) (â‚©) -317.243
Beta 1.01
Volatility % 30.09
14-Day RSI 66.69
14-Day ATR (â‚©) 634.2335
20-Day SMA (â‚©) 7907.5
12-1 Month Momentum % -22.3
52-Week Range (â‚©) 5450 - 9890
Shares Outstanding (Mil) 34.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medipost Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Medipost Co Ltd Stock Events

Financials Calendars
Event Date Price(â‚©)
No Event Data

Medipost Co Ltd Frequently Asked Questions

What is Medipost Co Ltd(XKRX:078160)'s stock price today?
The current price of XKRX:078160 is â‚©9300.00. The 52 week high of XKRX:078160 is â‚©9890.00 and 52 week low is â‚©5450.00.
When is next earnings date of Medipost Co Ltd(XKRX:078160)?
The next earnings date of Medipost Co Ltd(XKRX:078160) is .
Does Medipost Co Ltd(XKRX:078160) pay dividends? If so, how much?
Medipost Co Ltd(XKRX:078160) does not pay dividend.

Press Release

Subject Date
No Press Release